Congenital iodine-deficiency syndrome, myxedematous type is a condition resulting from inadequate iodine during fetal development, leading to severe hypothyroidism and associated myxedema. This syndrome is clinically significant as it can cause developmental delays, growth retardation, and cognitive impairments. Accurate coding with ICD-10 Code E00.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that affected individuals receive appropriate care and resources.
ICD-10 Code E00.1 represents Congenital iodine-deficiency syndrome, myxedematous type, a disorder caused by insufficient iodine during pregnancy, leading to hypothyroidism in the newborn. This code should be used in clinical documentation and billing when diagnosing patients with this condition, ensuring accurate representation of the underlying disease and facilitating appropriate treatment and management.
Congenital iodine-deficiency syndrome, myxedematous type is primarily caused by maternal iodine deficiency during pregnancy, leading to impaired thyroid hormone production in the fetus. This condition can progress to severe developmental issues and requires immediate medical attention to prevent long-term complications.
ICD-10 Code E00.1 is utilized in SOAP notes to document the diagnosis of Congenital iodine-deficiency syndrome, myxedematous type. It plays a crucial role in capturing symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code E00.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Congenital iodine-deficiency syndrome, myxedematous type. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Congenital iodine-deficiency syndrome, myxedematous type requires prompt medical intervention to manage hypothyroidism and prevent complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E00.1 is critical for billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 84443 | Thyroid stimulating hormone (TSH) test |
| 84436 | Thyroxine (T4) test |
| 99213 | Established patient office visit, Level 3 |
Common Questions About Using ICD-10 Code E00.1 for Congenital iodine-deficiency syndrome, myxedematous type
What are the long-term effects of Congenital iodine-deficiency syndrome?
Long-term effects can include developmental delays, cognitive impairments, and growth retardation. Early diagnosis and treatment with thyroid hormone replacement can mitigate some of these effects.
How is Congenital iodine-deficiency syndrome diagnosed?
Diagnosis is typically made through newborn screening tests that measure thyroid hormone levels, alongside clinical evaluation of symptoms such as myxedema and growth issues.
Is Congenital iodine-deficiency syndrome preventable?
Yes, adequate iodine intake during pregnancy can prevent this condition. Public health initiatives often promote iodine supplementation for pregnant women.
What is the treatment for Congenital iodine-deficiency syndrome?
The primary treatment involves lifelong thyroid hormone replacement therapy, typically with levothyroxine, to manage hypothyroidism and support normal growth and development.
Clinical Notes
SOAP notes
DAP notes
AI medical notes